Suppr超能文献

快速眼动睡眠行为障碍筛查问卷在中国的效度验证。

Validation of the rapid eye movement sleep behavior disorder screening questionnaire in China.

作者信息

Wang Yan, Wang Zong-Wen, Yang Yue-Chang, Wu Hui-Juan, Zhao Hong-Yi, Zhao Zhong-Xin

机构信息

Department of Neurology, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China.

Sleep Center, Changzheng Hospital, Second Military Medical University, Shanghai, China.

出版信息

J Clin Neurosci. 2015 Sep;22(9):1420-4. doi: 10.1016/j.jocn.2015.03.008. Epub 2015 Jul 9.

Abstract

We validated the Chinese version of the rapid eye movement sleep behavior disorder (RBD) screening questionnaire (RBDSQ) and calculated its cut-off value for idiopathic or symptomatic sleep behavior disorders (iRBD or sRBD) in Chinese people. Patients with RBD (n=63) and controls (n=165) were enrolled. After all subjects had completed a structured interview, the Chinese version of the RBDSQ and the video polysomnography test, we evaluated the reliability, areas under the curves and the best cut-off values of the RBDSQ and investigated the utility of RBDSQ for iRBD and sRBD in China. We found that Cronbach's alpha was 0.769 and the test-retest reliability was 0.916. RBDSQ scores in iRBD and sRBD patients were similar and higher than those in controls. A total of five points represented the best cut-off value for detecting all RBD patients. In Parkinson's disease, a total score of six points represented the best cut-off value for detecting sRBD. There was no statistically significant difference in total RBDSQ score between iRBD and sRBD, or male and female patients. There was no significant correlation between the RBDSQ score and duration or severity of RBD symptoms. The Chinese version of the RBDSQ had high sensitivity, specificity and reliability and could be used as a tool for screening RBD patients in China.

摘要

我们对快速眼动睡眠行为障碍(RBD)筛查问卷(RBDSQ)的中文版进行了验证,并计算了其在中国人群中特发性或症状性睡眠行为障碍(iRBD或sRBD)的临界值。纳入了63例RBD患者和165例对照者。在所有受试者完成结构化访谈、RBDSQ中文版及视频多导睡眠图测试后,我们评估了RBDSQ的信度、曲线下面积及最佳临界值,并研究了RBDSQ在中国iRBD和sRBD中的应用价值。我们发现Cronbach's α系数为0.769,重测信度为0.916。iRBD和sRBD患者的RBDSQ评分相似且高于对照组。总分5分是检测所有RBD患者的最佳临界值。在帕金森病中,总分6分是检测sRBD的最佳临界值。iRBD与sRBD患者之间、男性与女性患者之间的RBDSQ总分无统计学显著差异。RBDSQ评分与RBD症状的持续时间或严重程度无显著相关性。RBDSQ中文版具有较高的敏感性、特异性和信度,可作为中国RBD患者的筛查工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验